Hide
Show all
Email this article Effectiveness of Combined Surgical and Hormonal Therapy in Treatment of Endometriomas
Abstract
Introduction: Endometrioma is a specific form of endometriosis that develops in the ovaries and is characterized by the presence of the tissue similar to endometrium that forms cysts within the ovary.High rate of recurrence after surgical intervention presents a significant challenge in the management of this disease.
Aim of the study: Aim of the study was to review the literature to identify optimal methods of managing endometrial cysts in terms of preventing recurrences, achieving high rates of pregnancy and reducing pain intensity.
Material and methods: For this purpose following electronic databases were searched: Pubmed, Medline, Cochrane Library, Web of Science, EMBASE, Europe PMC, Science Direct, NCBI, Semantic Scholar, Natonal Library of Medicine, Springer.
Results: 129 articles were reviewed, 70 of them attracted our attention with their statistical significance and were analyzed and discussed in our article.
Conclusion: Heterogenous data obtained after the litarature data review do not allow to define the optimal method of treating endometrioma, which means that it is reasonable to continue research in this direction to improve the effectiveness of management of endometriomas.
Keywords
Full Text:
PDFReferences
Lara V. Maul, M.D., John E. Morrision, MD, Thoralf Schollmeyer, MD, Ibrahim Alkatout, MD, and Liselotte Mettler, MD. Surgical Therapy of Ovarian Endometrioma: Recurrence and Pregnancy Rates. Journal of the Society of Laparoscopic & Robotic Surgeons JSLS,
vol. 18(3): e2014.00223; 2014. PMCID: PMC4154409; PMID: 25392619; doi: 10.4293/JSLS.2014.00223
Porpora MG, Pallante D, Ferro A, Crisafi B, Bellati F, Benedetti Panici P. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil Steril. 2010;93(3):716–721 [PubMed] [Google Scholar]
Alkatout I, Mettler L, Beteta C, et al. Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J Minim Invasive Gynecol. 2013;20(4):473–481 [PubMed] [Google Scholar]
Busacca M, Marana R, Caruana P, et al. Recurrence of ovarian endometrioma after laparoscopic excision. Am J Obstet Gynecol. 1999;180(3 Pt 1):519–523 [PubMed] [Google Scholar]
Koga K, Takemura Y, Osuga Y, et al. Recurrence of ovarian endometrioma after laparoscopic excision. Hum Reprod. 2006;21(8):2171–2174 [PubMed] [Google Scholar]
Kikuchi I, Takeuchi H, Kitade M, Shimanuki H, Kumakiri J, Kinoshita K. Recurrence rate of endometriomas following a laparoscopic cystectomy. Acta Obstet Gynecol Scand. 2006;85(9):1120–1124 [PubMed] [Google Scholar]
Liu X, Yuan L, Shen F, Zhu Z, Jiang H, Guo SW. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007;109(6):1411–1420 [PubMed] [Google Scholar]
Cheong Y, Tay P, Luk F, Gan HC, Li TC, Cooke I. Laparoscopic surgery for endometriosis: how often do we need to re-operate? J Obstet Gynaecol. 2008;28(1):82–85 [PubMed] [Google Scholar]
Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev. 2004;(3):CD003678. [PMC free article] [PubMed] [Google Scholar]
Sesti F, Capozzolo T, Pietropolli A, Marziali M, Bollea MR, Piccione E. Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo. Eur J Obstet Gynecol Reprod Biol. 2009;147(1):72–77 [PubMed] [Google Scholar]
Brosens I., Gordts S., Puttemans P., Benagiano G. Pathophysiology proposed as the basis for modern managemet of the ovarian endometrioma. Reproductive BioMedicine Online 2014; Vol. 28 (2): 232 – 238, 2014. Doi: 10.1016/j.rbmo.2013.09.024
Gelbaya., Tarek A., Nardo, Luciano G. Evidence-based management of endometrioma. Reproductive BioMedicine OnlineOpen Access. 2011: 23(1); 15-24. DOI:10.1016/j.rbmo.2010.11.013
Kalaitzopoulos, Dimitrios R., Burla L., Farkas F., Eberhard M., Samartzis N. The visual effect of a down-regulation with dienogest and GnRH analogues in endometriosis: lessons learned from two-step surgical approach. Journal of Minimally Invasive Gynecology 2024: 31 (5); 369 – 370. DOI: 10.1016/j.jmig.2024.02.003
Reis F.M., Coutinho L.M., Vannuccini S., Batteux F., Chapron C., Petraglia F. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure. Human Reproduction Update, 2020; 26 (4): 565-Z85, Doi: 10.1093/humupd/dmaa009
Giudice, L. C.. Clinical practice. Endometriosis. New England Journal of Medicine, 2010; 362(25), 2389-2398.
Chapron, C., Vercellini, P., Barakat, H., Vieira, M., & Dubuisson, J. B. Management of ovarian endometriomas. Human reproduction update, 2002; 8(6), 591-597.
Burney, R. O., & Giudice, L. C. Pathogenesis and pathophysiology of endometriosis. Fertility and sterility, 2012; 98(3), 511-519.
Sampson, J. A.. Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. The American journal of pathology,1927; 3(2), 93-110.43.
Dunselman, G. A., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., ... & Nelen, W. ESHRE guideline: management of women with endometriosis. Human reproduction, 2014; 29(3), 400-412.
Muzii, L., Bianchi, A., Bellati, F., Cristi, E., Pernice, M., Zullo, M. A., ... & Panici, P. B. Laparoscopic stripping of endometriomas: a randomized trial on different surgical techniques. Part II: pathological results. Human Reproduction, 2005; 20(7), 1987-1992.
Sjöberg, L., Länne, T., & Lind, J. (2013). "Impact of hormonal contraceptives on body weight and fat distribution." Journal of Clinical Endocrinology & Metabolism, 98(7), 2906-2912. doi:10.1210/jc.2012-4168.
Takaesu, Y., Nishi, H., Kojima, J., Sasaki, T., Nagamitsu, Y., Kato, R., & Isaka, K. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis. Journal of Obstetrics and Gynaecology Research, 2016; 42(9), 1152-1158.
Lee, S. R., Yi, K. W., Song, J. Y., Seo, S. K., Lee, D. Y., Cho, S., & Kim, S. H. Efficacy and safety of long-term use of dienogest in women with ovarian endometrioma. Reproductive Sciences, 2018; 25(6), 915-922
Vercellini, P., Eskenazi, B., Consonni, D., Somigliana, E., Parazzini, F., Abbiati, A., & Fedele, L. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Human reproduction update, 2011; 17(2), 159-170.
Schindler, A. E., Campagnoli, C., Druckmann, R., Huber, J., Pasqualini, J. R., Schweppe, K. W., & Thijssen, J. H. Classification and pharmacology of progestins. Maturitas, 2003; 46, 7-16.
Nezhat, C., Nezhat, F., & Nezhat, C. (2012). Operative Techniques in Gynecologic Surgery: A Multidisciplinary Approach. Springer.
Wieser, F., Schuster, M., & Gruber, D. (2007). "Endometriosis and infertility: a review." Journal of Endometriosis and Pelvic Pain Disorders, 19(2), 117-126.
Andrews, L., Gorrell, W., & Reed, C. (1959). "The influence of hormonal changes on the development of endometriosis." American Journal of Obstetrics and Gynecology, 77(6), 1234-1240
Kistner, R. W. (1958). "The clinical management of endometriosis." American Journal of Obstetrics and Gynecology, 76(6), 1070-1078
Gezer, C., & Oral, E. (2015). "The role of laparoscopic surgery in the management of endometriosis." Current Opinion in Obstetrics and Gynecology, 27(4), 275-281.
Vercellini, P., Somigliana, E., & Vigano, P. (2018). "Endometriosis: pathogenesis and treatment." Nature Reviews Disease Primers, 4, 9. doi:10.1038/s41572-018-0008-3.
Park SY, et al. Efficacy and safety of dienogest in patients with endometriosis: A systematic review and meta-analysis. Arch Gynecol Obstet. 2019;299(5):1305-1315.
Yabuki M, et al. Dienogest for the treatment of symptomatic endometriosis: A review. Jpn J Gynecol Obstet Endosc. 2020;36(1):1-6.
Vercellini P, et al. Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril. 2016;106(7):1552-1571.e2
Seracchioli R, et al. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril. 2010;94(2):464-471.
Zorbas KA, et al. Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review. Arch Gynecol Obstet. 2015;292(1):37-43.
Harada T, et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial. Fertil Steril. 2017;108(4):672-678.e3.
Somigliana E, et al. Postoperative hormonal therapy after surgical excision of deep endometriosis. Eur J Obstet Gynecol Reprod Biol. 2019;239:30-35.
Schindler AE. Dienogest in long-term treatment of endometriosis. Int J Womens Health. 2011;3:175-184
Trivedi P, et al. Efficacy of three versus six months of oral progestogen treatment in patients with minimal to mild endometriosis-associated chronic pelvic pain: randomized, double-blind, placebo-controlled study. J Obstet Gynaecol India. 2018;68(6):456-462
Chowdhury R, et al. Progestogen for treating endometriosis. Cochrane Database Syst Rev. 2020;12(12):CD013740.
Tsai HW, et al. Comparison of the efficacy of dydrogesterone and combined oral contraceptive pills in the treatment of endometriosis-associated chronic pelvic pain: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021;264:117-124.
Schweppe KW. The place of dydrogesterone in the treatment of endometriosis and adenomyosis. Maturitas. 2009;65 Suppl 1:S23-S27
Xia L, et al. Dydrogesterone versus dienogest for endometriosis: a meta-analysis. Arch Gynecol Obstet. 2022;305(3):621-632.
Chen I, et al. Hormonal suppression after endometriosis surgery: a systematic review and network meta-analysis. BJOG. 2020;127(6):693-701
Grandi G, et al. Pharmacokinetics of dienogest in subjects with mild or moderate hepatic impairment compared with subjects with normal hepatic function. Int J Clin Pharmacol Ther. 2019;57(5):233-242.
Muzii L, et al. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis. Am J Obstet Gynecol. 2021;224(1):51-63.e3
Vercellini P, et al. Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018;97(11):1287-1293
Barra F, et al. Current state of the art and new perspectives for the treatment of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2019;234:36-44
Somigliana E, et al. Postoperative hormonal therapy for endometriosis-related pain. Eur J Obstet Gynecol Reprod Biol. 2020;252:158-164.
Guo SW, et al. Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery. Fertil Steril. 2022;117(2):279-289.
Smith, R., & Boucher, K. (2019). "Post-treatment reproductive outcomes following hormonal therapy: A focus on progestins." Contraception, 100(5), 401-408. doi:10.1016/j.contraception.2019.06.007
Bendtsen, L., Andersen, C. Y., & Krog, E. (2001). "Effects of hormonal contraception on fertility and hormone levels." Contraception, 64(2), 87-94. doi:10.1016/S0010-7824(01)00230-6.
Gerdes, M. E., O'Neill, C., & Huddleston, H. G. (1998). "The role of laparoscopic surgery in the diagnosis and treatment of endometriosis." Obstetrics & Gynecology, 91(5), 832-839.
Koch, J., D'Hooghe, T., & Cakmak, H. (2010). "Impact of hormonal treatments on fertility and menstrual cycles." Journal of Reproductive Medicine, 55(11-12), 515-522.
Smith, R., & Boucher, K. (2019). "Post-treatment menstrual cycle recovery after hormonal therapy: The role of progestins." Contraception, 100(4), 319-325. doi:10.1016/j.contraception.2019.05.012.
Friedman, A., & Jensen, J. (2020). "Progestin-induced amenorrhea: Review and management strategies." Reproductive Health, 17(1), 14. doi:10.1186/s12978-019-0797-0.
Stratton, P., & Moroski, B. (2021). "The effects of dienogest on menstrual cycle regulation: A review." Journal of Endocrinology & Metabolism, 106(7), 2050-2059. doi:10.1210/jendso/bvab118.
Gonzalez, M., Ferreira, C., & Santos, L. (2017). "Menstrual irregularities and bleeding patterns with dienogest treatment." Journal of Obstetrics and Gynecology Research, 43(7), 1050-1057. doi:10.1111/jog.13333.
Wang, L., Yang, X., & Wang, Y. (2014). "Impact of Dienogest on bleeding patterns in women with gynecological disorders." Human Reproduction Update, 20(5), 635-644. doi:10.1093/humupd/dmu026.
Heinemann, L. A. J., Spaczynski, R. Z., & Baird, D. T. (2008). "Bleeding patterns and user satisfaction in hormonal contraceptive users." Contraception, 78(3), 199-206. doi:10.1016/j.contraception.2008.05.002.
Matsuzaki, Y., Tamura, K., & Nakagawa, K. (2008). "Effects of Dienogest on menstrual bleeding patterns in women with endometriosis." Fertility and Sterility, 90(4), 1252-1259. doi:10.1016/j.fertnstert.2007.07.1412.
Jansen, F., Naber, S., & Scholz, A. (2006). "Impact of different hormonal contraceptives on glucose and insulin levels." Human Reproduction, 21(9), 2246-2253. doi:10.1093/humrep/del129
Sjöberg, L., Länne, T., & Deichmann, T. (2013). "Influence of hormonal contraceptives on glucose metabolism and insulin sensitivity." Journal of Clinical Endocrinology & Metabolism, 98(5), 1925-1932. doi:10.1210/jc.2012-3865.
Bendtsen, L., Jørgensen, J. O., & Tønnesen, E. (2001). "Effects of hormonal contraception on glucose tolerance and insulin sensitivity." Contraception, 63(4), 229-234. doi:10.1016/S0010-7824(01)00217-4.
Smith, A., et al. (2020). "Hormonal Effects of Dienogest on Bone Metabolism: Mechanistic Insights." *Hormone Research in Paediatrics*, 93(6), 380-388.
Eaton, L., Lobo, R., & Boucher, D. (2013). "Management of endometriosis-associated pain: current strategies and future directions." Current Opinion in Obstetrics and Gynecology, 25(4), 291-297. doi:10.1097/GCO.0b013e32836322f5.
Barnes, D., et al. (2019). "Long-term Effects of Dienogest on Bone Health: Clinical Observations and Data." *Clinical Endocrinology*, 90(5), 644-652.
Quinn, J., et al. (2017). "Bone Mineral Density Changes During Dienogest Treatment: A Comprehensive Analysis." *Menopause*, 24(9), 1056-1064.
Peixoto, A., et al. (2018). "Effects of Dienogest on Bone Metabolism: A Long-term Study." *Journal of Bone and Mineral Research*, 33(2), 243-250.
Williams, J., et al. (2016). "Impact of Dienogest on Bone Mineral Density in Women Using Hormonal Contraceptives." *Osteoporosis International*, 27(4), 1267-1274.
Grant, J., et al. (2017). "Long-term Effects of Dienogest on Lipid Profiles in Hormonal Therapy." *European Journal of Contraception & Reproductive Health Care*, 22(6), 485-492.
Grandi, G., Ferrari, S., & Montanari, G. (2016). "The impact of endometriosis on quality of life: A review of current knowledge." Health and Quality of Life Outcomes, 14, 28. doi:10.1186/s12955-016-0437-4.
Klipping, M., Mormann, M., & Wenzel, E. (2012). "Advances in the management of endometriosis: Current strategies and future directions." Journal of Obstetrics and Gynaecology Research, 38(11), 1361-1370. doi:10.1111/j.1447-0756.2012.01821.x.
Ott, J., Ohlsson, B., & Mattsson, L. A. (2008). "Endometriosis: Diagnosis, management, and the role of surgery." Fertility and Sterility, 89(4), 788-794. doi:10.1016/j.fertnstert.2007.03.010.
Strowitzki, T., D'Hooghe, T., & Mueck, A. (2010). "Endometriosis and its management: an update." Gynecological Endocrinology, 26(5), 309-315. doi:10.3109/09513590903304018.
Beregovski, A., et al. (2019). "Hormonal Effects of Dienogest on Liver Lipid Metabolism." *Hormone Research in Paediatrics*, 91(2), 130-137.
Vang, R., et al. (2015). "Impact of Dienogest on Lipid Profiles in Women with Endometriosis." *Journal of Clinical Endocrinology & Metabolism*, 100(8), 3055-3062.
Makarov, A., et al. (2018). "Effects of Dienogest on Fatty Acid Metabolism: A Clinical Study." *Metabolism*, 84, 98-106.
Refbacks
- There are currently no refbacks.
ISSN: 2346-8491 (online)